Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum
The Readout Loud
00:00
Novartis Recruits Sandford Bernstein Analyst Ronnie Gow
In novarts earnings, they announce their hiring sandford bernstein analyst ronnie gow as chief strategy and growth officer. I mean, we see people move from the analist signed to the industry side all the time, but an or this one kind of stuck out litle bout damie. And howcome? Yet, i think ronny gall has distinguished himself over now, two decades as a cellside analyst,. But in recent years, as a pretty pointed critic of the companies that he covers.
Transcript
Play full episode
